Treace Medical Concepts Inc. logo

Treace Medical Concepts Inc.

TMCI | undefined
Chart Builder DCF Calculator
-
At close: undefined
-
After-hours:

Market Data

Market Cap
$290.63M
Enterprise Value
$258.1M
Beta
1.41
Average Volume
622.8K
Shares Outstanding (Diluted)
65.05M
Shares Change YoY
3.24%
Institutional Ownership
55.71%
Exchange
NASDAQ
ISIN
US89455T1097

Price Performance

Price Change 1M
3.2%
Price Change 3M
-0.2%
Price Change 6M
255.6%
Price Change YTD
79.2%
Price Change 1Y
-35.1%
Price Change 3Y
-66.5%
Price Change 5Y
-84.7%
1M CAGR (ann.)
-5.9%
1Y CAGR (ann.)
-37.7%
5Y CAGR (ann.)
-30.5%
All-Time CAGR
-27.5%

Valuation

PE Ratio
-4.82
Forward PE
N/A
PEG Ratio
0.27
Forward PEG
0.55
PS Ratio
1.42
Forward PS
1.30
PB Ratio
4.29
P/FCF Ratio
-11.60
P/Adj. FCF Ratio
-5.27
P/OCF Ratio
-20.36
EV/Sales
1.26
EV/EBIT
-6.55
EV/EBITDA
-5.40
EV/FCF
-10.31
Earnings Yield
-20.8%
FCF Yield
-8.6%
Adj. FCF Yield
-19.0%

Financial Health

Net Cash
$32.53M
Total Debt
$13.09M
Cash & Short-Term Investments
$45.62M
Total Assets
$181.06M
Current Ratio
2.90
Quick Ratio
1.95
Debt / Equity Ratio
1.07
Debt / EBITDA
-0.27
Debt / FCF
-0.52
OCF / Debt
-1.11
Interest Coverage
-9.23
Altman Z-Score
0.29
Piotroski F-Score
3

Margins & Profitability

Gross Profit Margin
79.5%
Operating Profit Margin
-26.2%
EBITDA Margin
-22.0%
Net Profit Margin
-29.0%
FCF Margin
-12.2%
Adj. FCF Margin
-26.8%
SBC / Revenue
10.7%
SBC Impact (per share)
-120.0%

Returns

Return on Assets
-32.9%
Return on Equity
-74.1%
Return on Invested Capital
-37.5%
Return on Capital Employed
-38.5%
Return on Tangible Assets
-36.8%

Historical Growth (CAGR)

Revenue CAGR 3Y
7.1%
Revenue CAGR 5Y
21.4%
Revenue CAGR 10Y
N/A
EPS CAGR 3Y
4.9%
EPS CAGR 5Y
-5.7%
EPS CAGR 10Y
N/A
FCF CAGR 3Y
25.8%
FCF CAGR 5Y
13.8%
FCF CAGR 10Y
N/A

Analyst Forecasts

Analyst Rating
Hold
Analyst Count
9
EPS Growth Next 3Y
N/A
Revenue Growth Next 3Y
N/A
Earnings Date
Nov 4, 2026
EPS Estimate (next Q)
-$0.26
EPS Growth Est (next Q)
0.0%
Revenue Est (next Q)
$47.71M
Revenue Growth Est (next Q)
-5.0%

Fair Value Estimates

Graham Number
N/A
Graham Upside
N/A
Lynch Fair Value
N/A
Lynch Upside
N/A
Price Target
$8.60
Price Target Upside
92.0%

Cash Flow

Operating Cash Flow
$-14.58M
Free Cash Flow
$-25.05M
Adj. Free Cash Flow
$-55.1M
FCF Per Share
-$0.39
OCF Per Share
-$0.22
OCF/S Ratio
-7.1%

Income Statement

Revenue
$205.31M
Gross Profit
$163.12M
Operating Income
$-53.72M
EBITDA
$-47.79M
Net Income
$-59.52M
EPS (Diluted)
-$0.93
Revenue / Employee
$456.24K
Profit / Employee
$-132.26K
Employees
450

© 2026 bestshares.com. All rights reserved.